SCHEMBL26423231

SCHEMBL26423231

c1ccc2c(c1)oc1cc3nccnc3cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.53
MAPT P10636 6/20 0.50
NPC1 O15118 2/20 0.50
KDM4E B2RXH2 6/20 0.48
ALDH1A1 P00352 6/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
HPGD P15428 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
RAB9A P51151 2/20 0.48
MAOA P21397 3/20 0.44
HSD17B10 Q99714 3/20 0.42
GLA P06280 1/20 0.42
CYP3A4 P08684 1/20 0.42
PGAM1 P18669 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
NCOA1 Q15788 1/20 0.41
GAA P10253 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dibenzofuran SCHEMBL21647249 0.84 MEN1 (0.50) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL26423196 0.82 MAPT (0.49) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL26423212 0.82 MAPT (0.49) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL24910878 0.80 AHR (0.57) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL571563 0.79 AHR (0.71) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL16919496 0.79 AHR (0.71) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL26423381 0.78 MEN1 (0.39) MAPTNPC1KDM4EALDH1A1MEN1
SCHEMBL21890525 0.78 MEN1 (0.54) AHRMAPTNPC1KDM4EALDH1A1
SCHEMBL26423366 0.78 ROCK2 (0.39)
SCHEMBL26423389 0.78 NPC1 (0.31) AHRMAPTNPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 AHR 19/4885MAPT 1685/4885NPC1 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.